DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Amar Remedies Ltd

AMAR·BSE·Fast Moving Consumer Goods

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Fast Moving Consumer Goods · Personal Products

High-quality returns — 21% on equity

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

N/A

P/E Ratio

N/A

P/B Ratio

N/A

EPS

₹17.29

Book Value

N/A

ROE

20.60%Strong

ROCE

19.00%Efficient

Dividend Yield

N/A

Debt / Equity

N/A

Face Value

₹10.00

52W High

N/A

52W Low

N/A

Sector

Fast Moving Consumer Goods

Industry

Personal Products

Fairly Valued

Narrow moatHigh uncertainty

Fair value unavailable

/100

Business quality — Solid

Growth 50Profitability 52Efficiency 55Valuation 50

Plain English

Our view

High-quality returns — 21% on equity
Strong returns on equity (21%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

20.6%Strong

Above 15% is considered healthy for Indian equities

ROCE

19.0%Efficient

Above 18% means capital is working hard

Debt/Eq

—

Mkt Cap

—

P/B

—

EPS

₹17.29

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

N/A

No history

Profitability

Excellent

20.6% ROE

Financial health

N/A

No debt data

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Pros

Stock is trading at 0.06 times its book value
Company has delivered good profit growth of 23.6% CAGR over last 5 years

Forecast

News

Peers

Financials

Growth

Shareholding

No shareholding data

Ownership data is not available for this instrument.

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions